Today Castlight Health Inc Class B (NYSE:CSLT) Reported Decrease in Shorted Shares

May 24, 2018 - By Richard Conner

Castlight Health, Inc. (NYSE:CSLT) Logo

Investors sentiment decreased to 1.23 in 2017 Q4. Its down 0.82, from 2.05 in 2017Q3. It dived, as 10 investors sold Castlight Health, Inc. shares while 21 reduced holdings. 16 funds opened positions while 22 raised stakes. 46.25 million shares or 3.11% more from 44.86 million shares in 2017Q3 were reported.
Royal Bancshares Of Canada stated it has 0% in Castlight Health, Inc. (NYSE:CSLT). Tower Capital Ltd Co (Trc) holds 0.01% in Castlight Health, Inc. (NYSE:CSLT) or 14,190 shares. Tiaa Cref Investment Management Limited Liability Co holds 0% or 164,584 shares. Moreover, Bridgeway Mgmt has 0% invested in Castlight Health, Inc. (NYSE:CSLT) for 45,500 shares. Budros Ruhlin & Roe owns 10,000 shares. Atlantic Trust Limited Company holds 0% or 1,204 shares. Spark Investment Mgmt Limited Com has 21,300 shares for 0% of their portfolio. Swiss Fincl Bank invested 0% in Castlight Health, Inc. (NYSE:CSLT). Blair William Il stated it has 26,000 shares or 0% of all its holdings. 1.47M were accumulated by Gagnon Securities Llc. Virtu Financial Ltd Liability owns 0% invested in Castlight Health, Inc. (NYSE:CSLT) for 15,122 shares. Jaffetilchin Ptnrs Ltd Llc holds 0.01% or 11,926 shares. Acadian Asset Management Ltd Liability reported 0% stake. Needham Management Ltd stated it has 75,000 shares. Alliancebernstein Lp holds 0% of its portfolio in Castlight Health, Inc. (NYSE:CSLT) for 92,750 shares.

Since February 15, 2018, it had 0 buys, and 8 sales for $258,645 activity. The insider DOYLE JOHN C sold 3,328 shares worth $12,328. On Wednesday, May 16 Chan M.P. Eric sold $2,090 worth of Castlight Health, Inc. (NYSE:CSLT) or 550 shares.

The stock of Castlight Health Inc Class B (NYSE:CSLT) registered a decrease of 6.41% in short interest. CSLT’s total short interest was 4.19M shares in May as published by FINRA. Its down 6.41% from 4.48 million shares, reported previously. With 281,200 shares average volume, it will take short sellers 15 days to cover their CSLT’s short positions. The short interest to Castlight Health Inc Class B’s float is 6.9%.

The stock increased 1.41% or $0.05 during the last trading session, reaching $3.6. About 463,934 shares traded or 59.88% up from the average. Castlight Health, Inc. (NYSE:CSLT) has risen 6.15% since May 24, 2017 and is uptrending. It has underperformed by 5.40% the S&P500.

Castlight Health, Inc. operates a health benefits platform in the United States. The company has market cap of $489.82 million. The companyÂ’s platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs. It currently has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Castlight Health, Inc. (NYSE:CSLT) Ratings Coverage

Among 2 analysts covering Castlight Health (NYSE:CSLT), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Castlight Health had 6 analyst reports since January 31, 2018 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, February 21 by Cantor Fitzgerald. Cantor Fitzgerald maintained Castlight Health, Inc. (NYSE:CSLT) on Wednesday, April 25 with “Buy” rating. Cantor Fitzgerald upgraded the shares of CSLT in report on Wednesday, January 31 to “Overweight” rating. Cantor Fitzgerald maintained the shares of CSLT in report on Thursday, May 17 with “Buy” rating. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, May 10.

Another recent and important Castlight Health, Inc. (NYSE:CSLT) news was published by which published an article titled: “Market Trends Toward New Normal in Castlight Health, inc, Marriot Vacations Worldwide, AnaptysBio, Compass …” on May 18, 2018.

Castlight Health, Inc. (NYSE:CSLT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.